Tranexamic Acid for the Prevention of Blood Loss after Cesarean DeliveryLoı̈c Sentilhes, Catherine Deneux‐Tharaux, N. Sananès et al.|New England Journal of Medicine|2021Cited by 272
Randomized Phase III Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients with Muscle-invasive Bladder Cancer. Analysis of the GETUG/AFU V05 VESPER Trial Secondary Endpoints: Chemotherapy Toxicity and Pathological ResponsesChristian Pfister, Stéphane Culine, Aude Fléchon et al.|European Urology|2020Cited by 246
Maternal and perinatal outcomes following pre-Delta, Delta, and Omicron SARS-CoV-2 variants infection among unvaccinated pregnant women in France and Switzerland: a prospective cohort study using the COVI-PREG registryGuillaume Favre, Clémence Houssin, Brigitte Weber et al.|The Lancet Regional Health - Europe|2023Cited by 66
Tranexamic Acid for the Prevention of Blood Loss After Cesarean DeliveryLoı̈c Sentilhes, Patrick Rozenberg, Olivier Parant et al.|Obstetrical & Gynecological Survey|2021Cited by 25
Posttraumatic stress disorder 2 months after cesarean delivery: a multicenter prospective studyAlizée Froeliger, N. Sananès, Maëla Le Lous et al.|American Journal of Obstetrics and Gynecology|2024Cited by 18